Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?

This single-center study aimed to retrospectively evaluate the survival outcomes of patients with FIGO stage I clear cell and serous uterine carcinoma according to the type of adjuvant treatment received. The data were collected between 2003 and 2020 and only patients with stage I clear cell or sero...

Full description

Bibliographic Details
Main Authors: Manon Lefebvre, Mathilde Duchatelet, Houssein El Hajj, Antoine De Courrèges, Jennifer Wallet, Charlotte Bellier, Florence Le Tinier, Marie Cécile Le Deley, Carlos Martinez Gomez, Eric Leblanc, Fabrice Narducci, Delphine Hudry
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Current Oncology
Subjects:
clear cell uterine carcinoma
serous uterine carcinoma
stage I
survival
toxicities
Online Access:https://www.mdpi.com/1718-7729/30/1/90

Internet

https://www.mdpi.com/1718-7729/30/1/90

Similar Items